Noktome en es it fr

Noktome Brand names, Noktome Analogs

Noktome Brand Names Mixture

  • Tritec (ranitidine bismuth citrate salt)

Noktome Chemical_Formula


Noktome RX_link

Noktome fda sheet

Noktome FDA

Noktome msds (material safety sheet)

Noktome MSDS

Noktome Synthesis Reference

B. J. Price et al., U.S. Pat. 4,128,658 (1978)

Noktome Molecular Weight

314.405 g/mol

Noktome Melting Point

69-70 oC

Noktome H2O Solubility

24.7 mg/mL

Noktome State


Noktome LogP


Noktome Dosage Forms

Capsule; Liquid; Solution; Tablet; Syrup

Noktome Indication

Used in the treatment of peptic ulcer disease (PUD), dyspepsia, stress ulcer prophylaxis, and gastroesophageal reflux disease (GERD).

Noktome Pharmacology

Ranitidine is a histamine H2-receptor antagonist similar to cimetidine and famotidine. An H2-receptor antagonist, often shortened to H2 antagonist, is a drug used to block the action of histamine on parietal cells in the stomach, decreasing acid production by these cells. These drugs are used in the treatment of dyspepsia, however their use has waned since the advent of the more effective proton pump inhibitors. Like the H1-antihistamines, the H2 antagonists are inverse agonists rather than true receptor antagonists.

Noktome Absorption

Approximately 50% bioavailability orally.

Noktome side effects and Toxicity

LD50=77mg/kg (orally in mice). Symptoms of overdose include muscular tremors, vomiting, and rapid respiration.

Noktome Patient Information


Phenylketonurics: ZANTAC 25 EFFERdose Tablets contain phenylalanine 2.81 mg per 25 mg of ranitidine. ZANTAC 150 EFFERdose Tablets
contain phenylalanine 16.84 mg per 150 mg of ranitidine. ZANTAC EFFERdose Tablets should not be chewed, swallowed whole, or dissolved
on the tongue.

Noktome Organisms Affected

Humans and other mammals